Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo ‐controlled SCALE Teens trial

ConclusionsThis secondary analysis suggests that adolescents with obesity may experience significant BMI reductions after 56  weeks of liraglutide treatment, regardless of their sex, race, ethnicity, age, pubertal stage, glycemic status, obesity category, severity of depression symptoms, or weight variability. Early response may predict greater week 56 response.

Source: Pediatric Obesity - June 2, 2023 Category: Eating Disorders & Weight Management Authors: Megan O. Bensignor, Carolyn T. Bramante, Eric M. Bomberg, Claudia K. Fox, Paula M. Hale, Aaron S. Kelly, Rashmi Mamadi, Nandana Prabhu, Nina M. Harder ‐Lauridsen, Amy C. Gross Tags: ORIGINAL RESEARCH Source Type: research